Efficacy of Agastya Haritaki Rasayana and Gudardraka in the Management of Kaphaja Kasa (Wet Cough) in Children

A Comparative Clinical Study to Evaluate the Efficacy of Agastya Haritaki Rasayana and Gudardraka in the Management of Kaphaja Kasa (Wet Cough) in Children: An Open-Label Randomized Controlled Study - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/081085

Enrollment

124

Registered

2025-02-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J22- Unspecified acute lower respiratory infection Health Condition 2: J22- Unspecified acute lower respiratory infection

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children of aged between 8 to 12 years, irrespective of gender, religion and socio economical status. 2. Children presenting with clinical features (one or more) of Kaphaja Kasa lesser than 14days e.g. Snigdha (Unctuous), Ghana(Solid), Bahal Kaphasthivana (Cough with expectorant) other features associated with Peenasa (Nasal discharge), Chardi (Vomiting), Alparuk in Uras (Mild chest pain), Kanthaupalepa (Coating in the throat), Mandagni (Reduced appetite), and Sampoornavakshas (Fullness in the chest). 3. Parents/guardians willing to provide a written informed consent form for the participation of their children.

Exclusion criteria

Exclusion criteria: 1.Children suffering from any chronic illness of any other system. 2. Any type of Cough with chronicity of more than or equal to 14days. 3.Children with congenital anomalies and diagnosed case of asthma, pulmonary tuberculosis, COPD and chronic debilitating illnesses. 4.Children with neurological and hereditary diseases. 5. Any other condition that the Investigator thinks may jeopardize the study.

Design outcomes

Primary

Measure	Time frame
The primary outcome measure will change in the clinical symptoms grading of Kaphaj Kasa. Timepoint: 35 days	—

Secondary

Measure	Time frame
a. Change in Leicester cough Questionnaire to evaluate the impact of cough on quality of life. b. Change in values of laboratory parameters. CBC, KFT ,LFT to assesses safety of drug. c. PEFR to assess ventilation adequacy c. Assessment of the safety of the drug by documenting the occurrence of any adverse drug reactions (ADR)/adverse events (AE) during the course of the study.Timepoint: 35 days	—

Countries

India

Contacts

Public ContactProf Shambhu dayal Sharma

Institute of Ayurved Studies ands Research, Shri Krishna Ayush university , Kurukshetra , Haryana

sharmasddr@yahoo.com7988688231

Outcome results